This review article provides a systematic overview of the currently available evidence on the clinical effectiveness of particle therapy for the treatment of non-small cell lung cancer and summarizes findings of in silico comparative planning studies. Furthermore, technical issues and dosimetric uncertainties with respect to thoracic particle therapy are discussed.
No takes yet. Share an insight, caveat, or question.
Wink et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: